Module 5.2 Flashcards

1
Q

Introduction to Viruses

A

Viruses are obligate infectious agents (can only replicate in living cells).

Each virion has a protective outer layer (envelope) and genetic material (genome).

Viruses aren’t considered living organisms (no cells, growth, or energy production).

In humans, viruses cause a range of illnesses from mild (e.g., common cold) to severe.

Viruses constantly mutate and evolve, leading to new strains.

Many viruses originate in animals (e.g., birds, pigs, bats) and may jump to humans (e.g., Influenza A).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what do viral cycles start with

A

attachment to host receptor protein which then grants them access to the inside of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Structure of a Viral Particle

A

Viruses come in various shapes and sizes.

They contain single or double-stranded DNA or RNA as their genome.

Surrounded by a capsid (protein coat), some viruses have an outer envelope derived from the host cell membrane.

The outer layer (capsid or envelope) contains viral proteins that interact with receptor proteins on host cells.

This interaction allows the virus to attach to the host cell and enter it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what must viruses do to cause disease

A

replicate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

different mechanisms for viruses to enter cell

A

uncoating and synthesizing its genome, translating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The 1918 Influenza Pandemic

A

Both bacteria and viruses can cause infectious diseases.

Pandemics and epidemics occur when infection rates become uncontrollable.

The last major pandemic occurred in 1918, caused by an influenza virus.

WHO and other public health agencies have studied the 1918 pandemic to understand and better manage future pandemics.

Similar to COVID-19, the 1918 influenza had several waves of infection, with the second wave being especially lethal.

The virus spread in three waves and eventually evolved into the annual influenza seasons seen worldwide today.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Death Toll of the 1918 Influenza Pandemic

A

The 1918 influenza pandemic caused 50-100 million deaths worldwide.

⅓ of the global population contracted the influenza virus.

At the time, little was known about the disease, making it difficult to manage.

The origins of the virus are still unknown.

Unexpected deaths were common among young, healthy adults (ages 20-45).

One theory suggests that an overactive immune response in young adults led to secondary pneumonia and tissue damage, which contributed to the high mortality rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

1918 Epidemic in Canada

A

Influenza virus entered Canada through eastern ports (Quebec City, Montreal, Halifax).

Troop movements spread the virus across the country.

No quarantine measures for domestic travel.

Local authorities prohibited gatherings and isolated the sick, but measures failed.

Canada struggled due to lack of coordination and resources.

The Department of Health was founded in 1919 in response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The Impact of 1918 on Health Inequities in Canada

A

In 1918, medical treatment was only available to those who could afford it.

Poor, non-white, and Indigenous patients were often segregated to poorly staffed areas.

Many had to work through illnesses to afford basic needs.

Loss of parents led to children leaving school to work.

Deaths from influenza were high among Indigenous populations:

6.2/1000 non-Indigenous Canadians died.

Indigenous death rates ranged from 10.3 to 61 per 1000 in different regions.

In Okak, an Inuit village, 204/263 people died.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How and Indigenous Community Protected Itself

A

Influenza devastated remote Indigenous communities along the Pacific coast of the US and Canada.

In western Alaska, 30-95% of the population in some communities died within a week.

Some remote communities avoided the virus entirely.

Shishmaref, an island north of the Bering Strait, prevented the outbreak by stationing guards to restrict entry and exit, protecting other nearby communities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is covid caused by

A

the SARS-CoV-2 virus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SARS-CoV-2 Mechanism of Infection

A

Entry: Virions enter the body via the nasal/oral passages, traveling to the lungs.

Attachment: SARS-CoV-2 attaches to ACE2 receptors on lung cells using its spike protein.

Replication: The virus hijacks host cell machinery to replicate.

Release: New virions bud out of the host cell.

Infection: Virions spread to other tissues and may infect others if expelled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SARS-CoV-2 symptoms

A

Dry cough, tiredness, fever

Mild cases: loss of smell and taste

Brain fog has also been reported in some patients which persists months after infection is cleared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pandemic Timeline and Global Spread

A

Dec 2019: First pneumonia cases reported in Wuhan, China.

Jan 2020: WHO publishes outbreak news; China shares SARS-CoV-2 genetic sequence.

Mar 2020: WHO declares COVID-19 a pandemic; lockdowns and border closures implemented worldwide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Types of Variants and Mutation Classifications
of covid

A

Variant Under Monitoring (VUM): Potential impact on virus behavior but no strong evidence of epidemiological effect.

Variant of Interest (VOI): Increased transmissibility or immune evasion, but not yet a major public health threat (e.g., BA.2.86, JN.1).

Variant of Concern (VOC): Significant public health risk (e.g., Alpha, Beta, Gamma, Delta, Omicron).
As of March 2023, no new variants have been classified as VOCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Virus Genome and Structure
of covid

A

Structural proteins: spike, envelope, membrane, nucleocapsid

Non-structural proteins (NSPs): involved in replication

Spike protein: crucial for entry into human cells, targeted by vaccines, and undergoes conformational changes when binding to ACE-2 receptor.
Mutations in the spike protein affect viral transmissibility, immune evasion, and vaccine efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Impact of vaccines on Cases and Deaths

A

Before vaccines: High mortality, especially among older adults and vulnerable groups.

Vaccination campaigns (2021): Helped reduce deaths despite Omicron surges.

Post-vaccine: Cases rose with new variants, but deaths stayed lower due to vaccine protection.

13
Q

Early Waves of Infection covid

A

Wave 1 (Mar 2020): Initial outbreak, severe impact on long-term care facilities.

Wave 2 (Sept 2020 – Early 2021): Higher transmission during colder months.

Wave 3 & 4 (Spring – Summer 2021): Alpha and Gamma variants, increased lockdowns.

Wave 5 (Winter 2021-2022): Omicron BA.1 causes surge but lower mortality due to vaccines.

Wave 6 & 7 (Spring – Summer 2022): Omicron BA.2 and BA.5 dominate.

13
Q

Variant Evolution Over Time of covid

A

Pre-2021: Original SARS-CoV-2 strain was dominant.

Early 2021: Alpha, Beta, and Gamma variants emerge.

Mid-2021: Delta variant becomes dominant, increasing hospitalizations.

Late 2021 – 2022: Omicron replaces Delta, leading to waves of infection.

2023 – 2024: JN.1 and its descendants (KP, KS, and LB strains) dominate.

14
Q

COVID-19 Infection Control

A

SARS-CoV-2 Spread: Spreads via droplets and aerosols; doesn’t survive long on surfaces.

Measures to Stop Spread:

Distancing: Maintain 2-meter social distance.

Closures: Close high-contact areas/activities.

Masking: Wear masks and shields.

Washing: Wash hands, sanitize, clean surfaces.

Staying Home: Stay-at-home orders to limit spread.

Quarantining: Isolate travelers, symptomatic individuals, and close contacts.

Tracing: Track infected individuals and contacts.

15
Q

Cindy Mitchell

A

covid survivor
46 yo nurse from Napanee ontario

Caught COVID in spring 2021

Extremely sick for two weeks and visited emerg multiple times, got admitted to KGH in COVID-19 ward.

16
Q

pandemics and vulnerable populations

A

Elderly and Medically Unwell: High fatality rates in long-term care, impacting mental and physical health.

Low Socioeconomic Status: Job loss and high-risk work without paid sick leave or testing.

Racism and Discrimination: Asian communities, particularly Chinese, faced ostracization.

Mental Health and Addiction: Loss of social support and healthcare services.

Food Insecurity: Increased, with disrupted school food programs in countries like Canada, the U.S., and the UK.

16
Q

pandemic and Healthcare Disruptions

A

Delayed Medical Care: Routine screenings and exams were postponed.

Limited Access to Care: Shift to telehealth led to missed diagnoses.

Insurance Issues: Job loss caused loss of health insurance, especially in non-universal healthcare systems like the U.S.

17
Q

pandemics and living conditions and workplace risks

A

High-Density Housing Risks: Multi-unit dwellings saw higher infection and death rates.

Frontline Workers: Manufacturing, agriculture, and food production workers faced higher exposure with limited protective equipment and time off.

18
pandemics and Mental & Physical Health Decline
Social Isolation: Loss of normal activities, social interactions, and community engagement. Reduced Physical Activity: Gym closures, remote work, and canceled sports led to sedentary lifestyles. Increased Substance Abuse: Overeating, weight gain, and higher alcohol consumption became more prevalent.
19
Impact of COVID-19 on Indigenous Peoples in Canada
Indigenous communities in Canada already face higher rates of chronic health issues due to social disparities, colonization, and systemic racism. COVID-19 worsened these challenges, increasing: - Socioeconomic difficulties - Social isolation - Barriers to healthcare
20
The KIRK-19 Research Project
Study focused on Indigenous peoples with chronic health conditions in Kingston, Southeast Ontario. Researchers used qualitative interviews with 23 participants. Aimed to understand the impact of COVID-19 on healthcare, social services, and wellness. Followed OCAP principles (Ownership, Control, Access, Possession) for ethical and culturally safe research.
21
COVID-19 Vaccines : Viral Vector
Viral Vectors: Use of harmless viruses (e.g., adenoviruses) to deliver the gene sequence for the protein of interest. COVID-19 Vaccines: Adenovirus vectors encode the SARS-CoV-2 spike protein. Examples: - AstraZeneca: Vaxzevria - Janssen: Ad26.COV2.S
21
Positive Coping Mechanisms & Resilience for covid
Cultural & Community Support: Virtual/socially distanced cultural events maintained identity and resilience. Personal Relationships & Social Support: Family and community networks supported mental well-being. Socioeconomic Support Programs: Government and community programs addressed financial insecurity. Indigenous-Led Programs: Culturally appropriate care from Indigenous-led services was beneficial. Spirituality & Identity: Cultural traditions and strong identities fostered resilience. Final Report: Will include recommendations for improving healthcare, social services, and culturally safe support systems for Indigenous communities.
22
1918 Influenza vs COVID-19 Pandemic
Similarities: Both pandemics had rapid onset, multiple waves, and virus mutations, overwhelming healthcare systems. Public Health Improvements: Significant advances in public health responses over the past century. Vaccine Development: COVID-19 saw rapid vaccine development, unlike in 1918, helping prevent severe infections. Rollout Strategies: Vaccines prioritized frontline workers, vulnerable populations, and Indigenous communities. Canada's Approach: Vaccines distributed by descending age, starting with the elderly, to protect those most at risk.
23
COVID-19 Vaccines :mRNA
mRNA Vaccines: Contain synthetic mRNA that codes for a harmless piece of the virus's spike protein. Mechanism: The mRNA instructs cells to produce a fragment of the spike protein, triggering an immune response. Examples: - Pfizer-BioNTech: Comirnaty - Moderna: Spikevax
24
covid-19 vaccines: Whole Virus
Inactivated or Live Attenuated Vaccines: Contain a weakened or inactivated version of the virus to stimulate an immune response without causing disease. Mechanism: Exposes the immune system to SARS-CoV-2 without the risk of severe illness. Examples: - Sinovac: CoronaVac - Bharat Biotech: Covaxin
24
covid19 vaccine: Protein Subunit
Protein Subunit Vaccines: Contain harmless pieces of the virus, such as modified spike proteins, to stimulate the immune system. Mechanism: Uses protein fragments to trigger immune response without using live virus. Examples: - Novavax: Nuvaxovid - Anhui Zhifei Longcam: Zifivax
25
Vaccine Development & Rollout
Vaccine Development: Began immediately after the pandemic was declared in March 2020. Approval: By late 2020, several vaccines were approved. Canada's First Doses: Administered in December 2020. COVAX Initiative: Aimed to distribute vaccines to vulnerable populations globally.
25
Global Vaccination Trends
Mid-2021 Progress: Many countries made significant vaccination progress. Africa & Low-Income Regions: Lagged behind in vaccination coverage. CoVDP: WHO, UNICEF, and Gavi launched the COVID-19 Vaccine Delivery Partnership to support countries with low coverage.
26
Covid-19 vaccine: Virus-like Particles
Virus-like Particle (VLP) Vaccines: Use plants, bacteria, or other biotechnologies to produce particles that mimic the virus surface but are non-infectious and contain no genetic material. Mechanism: Mimics the virus structure to trigger an immune response without causing disease. Example: Medicago: Covifenz (uses plant-based technology to produce VLPs containing SARS-CoV-2 spike protein)
26
Canada’s Vaccine Strategy
Canada’s Vaccination Priorities: Focused on high-risk groups (long-term care, healthcare workers, Indigenous communities). Expanded by Age & Risk: Vaccination expanded to other groups based on age and risk factors. Special Clinics: Set up in outbreak areas and schools. Booster Doses: Introduced as new variants emerged.
27
Impact of Vaccination:
Increased vaccine coverage reduced COVID-19 deaths and hospitalizations, especially during later waves. Ontario data showed lower case rates and ICU admissions among vaccinated individuals, even with Omicron infections.
28
Ongoing Vaccine Updates of covid and vaccines
As the virus evolved, vaccines were updated, especially mRNA vaccines adapting to new variants. Novavax’s protein-based vaccine was available but less commonly used. COVID-19 vaccines are now administered alongside annual flu shots.
29
Amplifying Indigenous Voices in Health Promotion (protective factors, prevention, and spirituality)
Protective factors: - Self government - Land control - Control over cultural activities Prevention: - Community based approaches - Gatekeeper training - Peer support groups Spirituality: - Using Indigenous concepts of well being and spiritual practices; pow-wows, sweetgrass ceremonies, sweat lodges
30
Need for Indigenous Doctors
In 2016, 0.1% of doctors identified as Indigenous, though 4.5% of Canada’s population is Indigenous. Barriers for Indigenous medical students include MCAT access, travel costs, high tuition, and separation from communities. Low numbers of Indigenous healthcare workers contribute to systemic racism. Aboriginal Patient Navigators help but are underutilized due to limited awareness and patient vulnerability.